Evidence map›Paper›PMID 40913560›Full record

ArticleJournal of chemical theory and computation2025

Pruned-ADAPT-VQE: Compacting Molecular Ansätze by Removing Irrelevant Operators.

Nonia Vaquero-Sabater, Abel Carreras, David Casanova

Abstract read
In one paragraph

Article in Journal of chemical theory and computation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Counterdiabatic ADAPT-VQE for Molecular Simulation.Journal of chemical theory and computation · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nonia Vaquero-SabaterDonostia International Physics Center (DIPC), 20018 Donostia, Euskadi, Spain.
Abel CarrerasDonostia International Physics Center (DIPC), 20018 Donostia, Euskadi, Spain.ORCID 0000-0001-5529-2440
David CasanovaDonostia International Physics Center (DIPC), 20018 Donostia, Euskadi, Spain.ORCID 0000-0002-8893-7089

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The adaptive derivative-assembled problem-tailored variational quantum eigensolver (ADAPT-VQE) is one of the most widely used algorithms for electronic structure calculations in quantum computers. It adaptively selects operators based on their gradient, constructing ansätze that continuously evolve to match the energy landscape, helping avoid local traps and barren plateaus. However, this flexibility in reoptimization can lead to the inclusion of redundant or inefficient operators that have almost zero parameter value, barely contributing to the ansatz. We identify three phenomena responsible for the appearance of these operators: poor operator selection, operator reordering, and fading operators. In this work, we propose an automated, cost-free refinement method that removes unnecessary operators from the ansatz without disrupting convergence. Our approach evaluates each operator after ADAPT-VQE optimization by using a function that considers both its parameter value and position in the ansatz, striking a balance between eliminating low-coefficient operators while preserving the natural reduction of coefficients as the ansatz grows. Additionally, a dynamic threshold based on the parameters of recent operators enables efficient convergence. We apply this method to several molecular systems and find that it reduces ansatz size and accelerates convergence, particularly in cases with flat energy landscapes. The refinement process incurs, at most, a small additional computational cost and consistently improves or maintains ADAPT-VQE performance.

Identifiers

PMID40913560
PMCPMC12461939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.